SARM1 and amyotrophic lateral sclerosis: Moreover, SOD1 transgenic mouse models of ALS show little or no improvement when programmed axon death is blocked, either at the NMNAT (WLDS) level or the SARM1 level [88, 89] despite some evidence that the soma is impaired very early in these models [41].